Opioid drugmakers Insys Therapeutics and Mallinckrodt Pharmaceuticals face millions of dollars in settlement as a consequence of allegedly bribing doctors to prescribe their drugs.
US Food and Drug Administration (FDA) cracks down on false claims--issuing warning letters to companies for marketing supplements as valid treatment options for Alzheimer’s disease.
The US Food and Drug Administration (FDA) issued a warning letter to stem cell clinics about releasing unproven treatments which posed high health risks to patients.
Colorado passed a law requiring drug manufacturers to disclose the wholesale acquisition cost to prescribers in its effort to address the high cost of prescription drugs.
The recent FDA hearing raised the the marketing of recreational CBD as a medical product--an act which falls in violation of federal and state laws. This hearing was well attended by companies and individuals with invested interest in pushing their...
Tobacco companies are using social media platforms like Instagram and Twitter to promote e-cigs and other vape products to children as young as 13.